Invesco
GRCL

Invesco’s Gracell Biotechnologies Inc. American Depositary Shares GRCL Stock Holding History

Invesco’s Portfolio GRCL Stock Details GRCL Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
2023
Q4 		$631K Sell
2023
Q3 		$188K Buy
2023
Q2 		$242K Sell
2023
Q1 		$146K Buy
2022
Q4 		– Sell
2022
Q3 		$302K Buy
2022
Q2 		$515K Buy
2022
Q1 		$173K Buy
2021
Q4 		$238K Buy